Atlas Venture Associates Xi, L.p. - Net Worth and Insider Trading
Atlas Venture Associates Xi, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Atlas Venture Associates Xi, L.p. owns 7 companies in total, including Dyne Therapeutics Inc (DYN) , Akero Therapeutics Inc (AKRO) , and Ikena Oncology Inc (IKNA) among others .
Insider Ownership Summary of Atlas Venture Associates Xi, L.p.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
DYN | Dyne Therapeutics Inc | 2020-09-16 | 10 percent owner |
AKRO | Akero Therapeutics Inc | 2019-06-19 | 10 percent owner |
IKNA | Ikena Oncology Inc | 2021-03-25 | 10 percent owner |
2021-10-21 | 10 percent owner | ||
2021-02-01 | 10 percent owner | ||
2022-09-14 | 10 percent owner | ||
2023-11-03 | 10 percent owner |
Atlas Venture Associates Xi, L.p. Trading Performance
Atlas Venture Associates Xi, L.p. Ownership Network
Ownership Network List of Atlas Venture Associates Xi, L.p.
Ownership Network Relation of Atlas Venture Associates Xi, L.p.
Atlas Venture Associates Xi, L.p. Owned Company Details
What does Dyne Therapeutics Inc do?
Who are the key executives at Dyne Therapeutics Inc?
Atlas Venture Associates Xi, L.p. is the 10 percent owner of Dyne Therapeutics Inc. Other key executives at Dyne Therapeutics Inc include See Remarks Richard William Scalzo , Chief Medical Officer Wildon Farwell , and Chief Operating Officer Susanna Gatti High .
Dyne Therapeutics Inc (DYN) Insider Trades Summary
Over the past 18 months, Atlas Venture Associates Xi, L.p. made no insider transaction in Dyne Therapeutics Inc (DYN). Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 244,099 shares made by Jonathan Mcneill , a net sale of 194,534 shares made by Richard William Scalzo , and a net sale of 35,057 shares made by Wildon Farwell .
In summary, during the past 3 months, insiders sold 3,508,769 shares of Dyne Therapeutics Inc (DYN) in total and bought 0 shares, with a net sale of 3,508,769 shares. During the past 18 months, 5,486,089 shares of Dyne Therapeutics Inc (DYN) were sold and 3,583,447 shares were bought by its insiders, resulting in a net sale of 1,902,642 shares.
Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dyne Therapeutics Inc Insider Transactions
Atlas Venture Associates Xi, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Atlas Venture Associates Xi, L.p.. You might contact Atlas Venture Associates Xi, L.p. via mailing address: 400 Technology Square, 10th Floor, Cambridge Ma 02139.